Home
½ÃÀÛÆäÀÌÁö
Áö³È£º¸±â
·Î±×ÀÎ
ȸ¿ø°¡ÀÔ
±¸µ¶½Åû
Àüü±â»ç
2024-03-28 ¸ñ 17:22
±â»ç°Ë»ö
Cover Story
¼øȯ±â
³»ºÐºñ
È£Èí±â
¼Òȱâ
½Å°æ°ú
Á¤½Å°Ç°
°¨¿°³»°ú
Sub Story
Interview
Drug Review
Conference Report
Late Breaking Studies
Expert Opinion
Primary Expert Opinion
The Rare Disease
ÇмúÀÚ¹®À§¿ø
RTM
»ó´Ü¿©¹é
񃯇
(Àüü 714°Ç)
Á¦¸ñº¸±â
Á¦¸ñº¸±â
Á¦¸ñ+³»¿ë
[Sub Story]
PPI ¾ÈÀü¼º È®ÀÎ, ¾ÆÁ÷ ³¡³ªÁö ¾Ê¾Ò´Ù?
ÀÓ¼¼Çü ±âÀÚ
2023-01-06 18:00
[Sub Story]
±¹³» À§¿° °ü¸®Àü·«, 8°³ Áú¹®¿¡ ´ã¾Ò´Ù
ÀÓ¼¼Çü ±âÀÚ
2023-01-06 17:25
[Sub Story]
PPI º´¿ë¿ä¹ýÀ¸·Î È¿°ú °È¡¤´ÜÁ¡ º¸¿Ï
ÀÓ¼¼Çü ±âÀÚ
2023-01-06 16:56
[Sub Story]
³úÁ¹Áß ¿¹¹æ¿¡ ½Ç·Î½ºÅ¸Á¹ DAPT ¼º°øÀû
ÀÌ»óµ· ±âÀÚ
2022-12-06 12:26
[Sub Story]
°íÇ÷¾Ð¡¤ÀÌ»óÁöÁúÇ÷Áõ¡¤´ç´¢º´
ÀÌ»óµ· ±âÀÚ
2022-12-06 12:26
¶óÀÎ
[Sub Story]
¾Æ½Ã¾ÆÀΡ¤À¯Áõ»ó¡¤ÁøÇ༺ ICAS µ¿¹Ý ³úÁ¹Áß ¿¹¹æÀü·«Àº?
ÀÌ»óµ· ±âÀÚ
2022-12-06 12:16
[Sub Story]
ÁýÁß Ç÷¾ÐÁ¶Àý·Î ³úÁ¹Áß¡¤Ä¡¸Å ¸·´Â´Ù
ÀÌ»óµ· ±âÀÚ
2022-12-06 11:38
[Sub Story]
½ºÅ¸Æ¾ ´Üµ¶¡¤ºñ½ºÅ¸Æ¾°è º´¿ë ³úÁ¹Áß ¿¹¹æÇýÅà ½Ã»ç
ÀÌ»óµ· ±âÀÚ
2022-12-06 11:34
[Sub Story]
¹«»ç°í DAPT ÈÄ ´Üµ¶Àüȯ Ŭ·ÎÇǵµ±×·¼ vs ¾Æ½ºÇǸ°
ÀÌ»óµ· ±âÀÚ
2022-12-06 11:20
[Sub Story]
6³â°üÂû¿¡¼µµ Ŭ·ÎÇǵµ±×·¼ ½Â¸® ±»È÷±â
ÀÌ»óµ· ±âÀÚ
2022-12-06 11:15
¶óÀÎ
[Sub Story]
´ëÇ÷°üÇÕº´Áõ ¿¹¹æ À§ÇÑ Ç÷¾Ð¡¤ÁöÁú¡¤Ç÷Àü¡¤Ç÷´ç Á¾ÇÕÄ¡·á Àü·«
ÀÌ»óµ· ±âÀÚ
2022-12-06 11:05
[Sub Story]
NOAC ³úÁ¹Áß ¿¹¹æÇýÅà £¾ ÃâÇ÷À§Çè
ÀÓ¼¼Çü ±âÀÚ
2022-12-06 10:58
[Sub Story]
Çѱ¹Àο¡¼ ½ºÅ¸Æ¾ÀÇ LDL-C °ÇÏÈ¿°ú
ÀÌ»óµ· ±âÀÚ
2022-11-16 12:10
[Sub Story]
´ëÇѹα¹Àº ¿Ö 55mg/dL ¹Ì¸¸ ¿Ü¸éÇÒ ¼ö ¾ø¾ú³ª?
ÀÌ»óµ· ±âÀÚ
2022-11-16 12:10
[Sub Story]
¼±¸´Â ¹» ±Ù°Å·Î 55mg/dL ¹Ì¸¸Á¶Àý ±Ç°íÇß³ª?
ÀÌ»óµ· ±âÀÚ
2022-11-16 12:09
¶óÀÎ
[Sub Story]
55mg/dL ¹Ì¸¸ ¸ñǥġ ¾à¹°Ä¡·á¿¡ ¹ÌÄ¡´Â ¿µÇâÀº?
ÀÌ»óµ· ±âÀÚ
2022-11-16 12:03
[Sub Story]
½ÉÇ÷°üÁúȯ 1Â÷¿¹¹æ¿¡ ½ºÅ¸Æ¾ ±Ç°í
ÀÌ»óµ· ±âÀÚ
2022-11-16 11:56
[Sub Story]
¿¡Á¦Æ¼¹Ìºê¡¤PCSK9¾ïÁ¦Á¦ ±Ç°íµî±Þ »óÇâ
ÀÌ»óµ· ±âÀÚ
2022-11-16 11:52
[Sub Story]
°íÁß¼ºÁö¹æÇ÷Áõ µ¿¹Ý½Ã ½ºÅ¸Æ¾¸¸À¸·Î ½ÉÇ÷°üÁúȯ ¸ø¸·¾Æ
ÀÌ»óµ· ±âÀÚ
2022-11-16 11:50
[Sub Story]
ÁöÁú¡¤Ç÷¾Ð Á¾ÇÕÄ¡·á Æз¯´ÙÀÓ ¿¸°´Ù
ÀÌ»óµ· ±âÀÚ
2022-11-16 11:42
-
1
2
3
4
5
6
7
8
9
10
´ÙÀ½
-
¿©¹é
Sub
news
¡°ACEI ÀÓ»ó±Ù°Å ³õ°í, ȯÀÚ ¼³µæÇÏÀÚ¡±
Q. Ç÷¾Ð°ÇÏ Ãø¸é¿¡¼ ACEIÀÇ Æ¯¼ºÀº?ù...
¡°SGLT-2i Ȳ±Ý±â´Â TZD¿Í º´¿ëÀ¸·ÎºÎÅÍ¡±
Q. SGLT-2iÀÇ °è¿È¿°ú¿¡ ´ëÇÑ °ßÇØ´Â...
¡°°í°µµ ½ºÅ¸Æ¾ Á¦Á¦ È¿°ú ´ëµîÇϳª ¾ÈÀü¼º ´Ù¸¦ ¼öµµ¡±
Q. CAD ȯÀÚÀÇ ÀÌ»óÁöÁúÇ÷Áõ Ä¡·áÀü·«Àº?...
¿©¹é
¿©¹é
Back to Top